Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.

Pohlmeyer CW, Gonzalez VD, Irrinki A, Ramirez RN, Li L, Mulato A, Murry JP, Arvey A, Hoh R, Deeks SG, Kukolj G, Cihlar T, Pflanz S, Nolan GP, Min-Oo G.

J Virol. 2019 Mar 21;93(7). pii: e01790-18. doi: 10.1128/JVI.01790-18. Print 2019 Apr 1.

PMID:
30700608
2.

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Veenhuis RT, Kwaa AK, Garliss CC, Latanich R, Salgado M, Pohlmeyer CW, Nobles CL, Gregg J, Scully EP, Bailey JR, Bushman FD, Blankson JN.

JCI Insight. 2018 Sep 20;3(18). pii: 122795. doi: 10.1172/jci.insight.122795. eCollection 2018 Sep 20.

3.

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses.

Pohlmeyer CW, Laskey SB, Beck SE, Xu DC, Capoferri AA, Garliss CC, May ME, Livingston A, Lichmira W, Moore RD, Leffell MS, Butler NJ, Thorne JE, Flynn JA, Siliciano RF, Blankson JN.

PLoS One. 2018 Feb 21;13(2):e0192098. doi: 10.1371/journal.pone.0192098. eCollection 2018.

4.

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG.

PLoS Med. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417. eCollection 2017 Nov.

5.

A CD3/CD28 microbead-based HIV-1 viral outgrowth assay.

Kuzmichev YV, Veenhuis RT, Pohlmeyer CW, Garliss CC, Walker-Sperling VE, Blankson JN.

J Virus Erad. 2017 Apr 1;3(2):85-89.

6.

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.

Walker-Sperling VE, Pohlmeyer CW, Veenhuis RT, May M, Luna KA, Kirkpatrick AR, Laeyendecker O, Cox AL, Carrington M, Bailey JR, Arduino RC, Blankson JN.

EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26.

7.

Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality.

Laskey SB, Pohlmeyer CW, Bruner KM, Siliciano RF.

PLoS Pathog. 2016 Aug 5;12(8):e1005689. doi: 10.1371/journal.ppat.1005689. eCollection 2016 Aug.

8.

The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication.

Walker-Sperling VE, Pohlmeyer CW, Tarwater PM, Blankson JN.

EBioMedicine. 2016 Jun;8:217-229. doi: 10.1016/j.ebiom.2016.04.019. Epub 2016 Apr 18.

9.

What can we do to reduce the viral reservoir in HIV-1-infected individuals?

Pohlmeyer CW, Walker-Sperling VE, Blankson JN.

Future Microbiol. 2016 Jul;11:839-42. doi: 10.2217/fmb-2016-0074. Epub 2016 Jul 15. No abstract available.

10.

A Human Immunodeficiency Virus Controller With a Large Population of CD4(+)CD8(+) Double-Positive T Cells.

Durand CM, Buckheit RW 3rd, Salgado M, Pohlmeyer CW, Walker-Sperling VE, Hegarty RW, Ambinder RF, Blankson JN.

Open Forum Infect Dis. 2015 Mar 20;2(2):ofv039. doi: 10.1093/ofid/ofv039. eCollection 2015 Apr.

11.

A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads.

Metcalf Pate KA, Pohlmeyer CW, Walker-Sperling VE, Foote JB, Najarro KM, Cryer CG, Salgado M, Gama L, Engle EL, Shirk EN, Queen SE, Chioma S, Vermillion MS, Bullock B, Li M, Lyons CE, Adams RJ, Zink MC, Clements JE, Mankowski JL, Blankson JN.

J Infect Dis. 2015 Nov 1;212(9):1387-96. doi: 10.1093/infdis/jiv230. Epub 2015 Apr 15.

12.

HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.

Salgado M, Swanson MD, Pohlmeyer CW, Buckheit RW 3rd, Wu J, Archin NM, Williams TM, Margolis DM, Siliciano RF, Garcia JV, Blankson JN.

J Virol. 2014 Mar;88(6):3340-52. doi: 10.1128/JVI.03380-13. Epub 2014 Jan 3.

13.

CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.

Pohlmeyer CW, Buckheit RW 3rd, Siliciano RF, Blankson JN.

Retrovirology. 2013 Dec 12;10:152. doi: 10.1186/1742-4690-10-152.

14.

In vivo organization of the FtsZ-ring by ZapA and ZapB revealed by quantitative super-resolution microscopy.

Buss J, Coltharp C, Huang T, Pohlmeyer C, Wang SC, Hatem C, Xiao J.

Mol Microbiol. 2013 Sep;89(6):1099-120. doi: 10.1111/mmi.12331. Epub 2013 Aug 14.

15.

Rapidly relocating molecules between organelles to manipulate small GTPase activity.

Phua SC, Pohlmeyer C, Inoue T.

ACS Chem Biol. 2012 Dec 21;7(12):1950-5. doi: 10.1021/cb300280k. Epub 2012 Sep 25.

16.

Spatio-temporal manipulation of small GTPase activity at subcellular level and on timescale of seconds in living cells.

DeRose R, Pohlmeyer C, Umeda N, Ueno T, Nagano T, Kuo S, Inoue T.

J Vis Exp. 2012 Mar 9;(61). pii: 3794. doi: 10.3791/3794.

17.

Triggering actin comets versus membrane ruffles: distinctive effects of phosphoinositides on actin reorganization.

Ueno T, Falkenburger BH, Pohlmeyer C, Inoue T.

Sci Signal. 2011 Dec 13;4(203):ra87. doi: 10.1126/scisignal.2002033.

18.

A photocleavable rapamycin conjugate for spatiotemporal control of small GTPase activity.

Umeda N, Ueno T, Pohlmeyer C, Nagano T, Inoue T.

J Am Chem Soc. 2011 Jan 12;133(1):12-4. doi: 10.1021/ja108258d. Epub 2010 Dec 13.

Supplemental Content

Loading ...
Support Center